Irinotecan
Irinotecan
ATX: L01CE02
Pharmacological group: Plant alkaloids and other natural products - Topoisomerase 1 (TOP1) inhibitors
Drug form: Concentrate for solution for infusion
Dosage and pack size: 100mg/5ml and 300mg/15ml in vials in package №1
Indication: Metastatic carcinoma of the colon or rectum as first-line treatment in combination with fluorouracil and leucovorin